Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Am J Public Health. 2012 Nov 15;103(1):105–111. doi: 10.2105/AJPH.2012.300819

TABLE 2.

Univariate Associations of Study Factors With Any Active Intravenous Drug Use During the 3-Year Follow-Up Among Hepatitis C Virus–Infected Patients Who Have Ever Used Injection Drugs: CHARM Cohort; Boston, MA; 2000–2006

Characteristics Active IDU, No./Total No. (%) PR (95% CI)
Demographic factors
Gender
 Male 84/187 (44.9) 0.79 (0.63, 1.00)
 Female 58/102 (56.9) 1.00 (Ref)
Age, y
 < 40 48/72 (66.7) 1.54 (1.23, 1.92)
 ≥40 94/217 (43.3) 1.00 (Ref)
Race/ethnicity
 Black 65/139 (46.8) 1.00 (Ref)
 White 41/84 (48.8) 1.04 (0.79, 1.38)
 Hispanic 35/61 (57.4) 1.23 (0.93, 1.62)
 Other 1/5 (20.0) 0.43 (0.07, 2.49)
Social factors
Incarcerated
 Ever 119/228 (52.2) 1.38 (0.98, 1.96)
 Never 23/61 (37.7) 1.00 (Ref)
Education
 < high school 66/129 (51.2) 1.08 (0.85, 1.36)
 ≥ high school 76/160 (47.5) 1.00 (Ref)
Married
 Yes 9/27 (33.3) 0.66 (0.38, 1.14)
 No 132/261 (50.6) 1.00 (Ref)
Unemployed
 Yes 124/220 (56.4) 2.16 (1.43, 3.27)
 No 18/69 (26.1) 1.00 (Ref)
Homeless
 Yes 25/32 (78.1) 1.72 (1.37, 2.15)
 No 117/257 (45.5) 1.00 (Ref)
Substance use factors
Alcohol use
 Active hazardous drinking 41/53 (77.4) 1.96 (1.55, 2.47)
 Any other alcohol use 18/39 (46.2) 1.17 (0.79, 1.71)
 No current alcohol use 70/177 (39.6) 1.00 (Ref)
Active cigarette smoking
 Yes 124/229 (54.2) 1.80 (1.20, 2.70)
 No 18/60 (30.0) 1.00 (Ref)
Age at initiation of IDU, y
 < 20 69/141 (48.9) 0.97 (0.76, 1.22)
 ≥ 20 72/142 (50.7) 1.00 (Ref)
History of daily cocaine use
 Yes 84/165 (50.9) 1.08 (0.85, 1.37)
 No 58/123 (47.2) 1.00 (Ref)
History of daily heroin use
 Yes 123/230 (53.5) 1.66 (1.13, 2.45)
 No 19/59 (32.2) 1.00 (Ref)
History of methadone treatment
 Yes 89/163 (54.6) 1.30 (1.01, 1.67)
 No 52/124 (41.9) 1.00 (Ref)
Clinical factors
HIV coinfection
 Yes 87/179 (48.6) 0.97 (0.76, 1.24)
 No 55/110 (50.0) 1.00 (Ref)
History of psychiatric disease
 Yes 90/173 (52.0) 1.28 (0.97, 1.68)
 No 42/103 (40.8) 1.00 (Ref)

Note. CHARM = Hepatitis C, HIV, and Related Morbidity; CI = confidence interval; IDU = intravenous drug use; PR = prevalence ratio. Status was at the baseline interview.